What type of drug is lvosidenib?

Ivosidenib is a type of targeted therapy called an enzyme inhibitor. Avosidenib works by blocking an abnormal enzyme that is produced by some cancer cells that have specific changes in the IDH-1 gene. Blocking the abnormal enzyme may cause cancer cells to differentiate and grow more slowly. Avonibis an isocitrate dehydrogenase-1 inhibitor. Its mechanism of action is to reduce the abnormal production of tumor metabolite2-hydroxyglutarate(2-HG), leading to the differentiation of malignant cells. If you want to get more high-quality information, you can contact Yaode . Yaode will do its best to learn more about high-quality overseas drugs for you.